Brian Lamon Named Chief Business Officer for Caris Life Sciences
Caris Life Sciences has hired Brian Lamon as Chief Business Officer, Head of BioPharma Business Development. Brian joins Caris from Bristol Myers Squibb, where he held several roles, most recently as Vice President, Development Team Lead, Genitourinary (GU) Malignancies. Brian also brings academic experience to his new role, previously serving Weill Medical College of Cornell University in New York as Assistant Dean of Research Development and Assistant Professor, Department of Pathology and Laboratory Medicine. Brian is still an Assistant Professor at Weill Medical College currently.
Caris Life Sciences is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions. Headquartered in Irving, TX, it has offices in Phoenix, Denver, New York, and Basel, Switzerland. Caris provides services throughout the U.S., Europe, Asia and other international markets